Showing results (11-20 of 153) with videos related to
Sort By:
Pageof 16
BMC Cancer|August 9, 2007
Paradoxes in carcinogenesis: new opportunities for research directionsStuart G Baker, Barnett S KramerStatistical Methods in Medical Research|September 24, 2005
Simple maximum likelihood estimates of efficacy in randomized trials and before-and-after studies, with implications for meta-analysisStuart G Baker, Barnett S KramerBMC Medical Research Methodology|September 10, 2003
A perfect correlate does not a surrogate makeStuart G Baker, Barnett S KramerBMC Bioinformatics|September 9, 2006
Identifying genes that contribute most to good classification in microarraysStuart G Baker, Barnett S KramerClinical Trials (London, England)|November 12, 2014
Evaluating surrogate endpoints, prognostic markers, and predictive markers: Some simple themesStuart G Baker, Barnett S KramerBMC Medical Research Methodology|October 6, 2004
The fallacy of enrolling only high-risk subjects in cancer prevention trials: is there a "free lunch"?Stuart G Baker, Barnett S Kramer, Donald CorleBMC Medical Research Methodology|March 27, 2002
Markers for early detection of cancer: statistical guidelines for nested case-control studiesStuart G Baker, Barnett S Kramer, Sudhir SrivastavaBMC Medical Research Methodology|July 5, 2003
Estimating the cumulative risk of false positive cancer screeningsStuart G Baker, Diane Erwin, Barnett S KramerBMC Medical Research Methodology|September 20, 2002
Statistical issues in randomized trials of cancer screeningStuart G Baker, Barnett S Kramer, Philip C ProrokDisease Markers|August 24, 2004
Development tracks for cancer prevention markersStuart G Baker, Barnett S Kramer, Philip C ProrokPageof 16